You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.
New Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma Jan ... naturally in the body after the repair is ... Brain Scan Predicts Effectiveness of Spinal Cord Surgery ...
One of the biggest factors determining pet insurance cost is the coverage. For example, a comprehensive policy that covers a range of treatments and also routine care will cost more than an ...
One of only a handful of academic centers in the United States dedicated to skeletal health, the Johns Hopkins Metabolic Bone and Osteoporosis Center is committed to providing patients and their ...
Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...
Learn more about whether Integra LifeSciences Holdings Corporation or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...